Guangzhou Innogen Pharmaceutical Group Co., Ltd engages in development of drugs. Its products are used for treatment of metabolic diseases, including diabetes, obesity, and MASH; and other major central nervous system diseases. The company was incorporated in 2014 and is based in Shanghai, China.